Bristol Myers Squibb Co.

Investors beware: ‘Magnificent Seven’ are starting to resemble ‘Nifty 50’ stocks that got crushed in the 1970s market crash

10:10 a.m. Dec. 2, 2023

- Joseph Adinolfi

Bristol Myers CEO Chris Boerner Buys Up Stock

1:56 p.m. Dec. 1, 2023

- Ed Lin

Bristol Myers Stock Is Slumping. One Director Bought Up Shares.

3:00 a.m. Dec. 1, 2023

- Ed Lin

Cabaletta Bio’s and Gracell’s stock falls sharply as FDA investigates risks of CAR-T therapy

5:04 p.m. Nov. 28, 2023

- Eleanor Laise

Dow refreshes highest close in nearly four months after Fed official’s remarks, with inflation data ahead

4:56 p.m. Nov. 28, 2023

- Frances Yue

Micron, Boeing, Acelyrin, PDD, ChargePoint, Affirm, and More Stock Market Movers

4:25 p.m. Nov. 28, 2023

- Joe Woelfel

Avidity Stock Soars on Collaboration Deal With Bristol Myers

10:02 a.m. Nov. 28, 2023

- Angela Palumbo

Avidity’s stock rockets on Bristol Myers deal that could mean $2.2 billion in milestone payments

8:33 a.m. Nov. 28, 2023

- Ciara Linnane

Avidity’s stock soars on news of expanded collaboration with Bristol Myers that includes potential to receive up to $2.2 billion in milestone payments

6:46 a.m. Nov. 28, 2023

- Ciara Linnane

Avidity’s stock soars 19% premarket

6:38 a.m. Nov. 28, 2023

- Ciara Linnane

Bristol Myers Squibb and Avidity to expand cardiovascular collaboration

6:37 a.m. Nov. 28, 2023

- Ciara Linnane

Avidity to receive $100 mln upfront from Bristol Myers Squibb with potential to earn up to $2.2 bln in milestone payments

6:37 a.m. Nov. 28, 2023

- Ciara Linnane

Dow Jones finishes over 200 points higher as S&P 500 moves out of correction

4:28 p.m. Nov. 20, 2023

- William Watts

Microsoft, Boeing, Bristol Myers, Penn Entertainment, Arm, and More Stock Market Movers

4:19 p.m. Nov. 20, 2023

- Joe Woelfel

Bristol Myers Squibb Falls After Drug Approval Delayed

9:42 a.m. Nov. 20, 2023

- Brian Swint

The stock market has rallied 63 times after a correction. Why this time is different, says Deutsche Bank.

8:57 a.m. Nov. 20, 2023

- Steve Goldstein

Bristol Myers Squibb, 2seventy bio shares fall as FDA delays action on cancer treatment

8:35 a.m. Nov. 20, 2023

- Eleanor Laise

Bayer shares plunge by more than 20% after trial of potential blockbuster drug halted

6:33 a.m. Nov. 20, 2023

- Jamie Chisholm

Pharma's Out of Favor. 5 Drug Stocks That Can Grow.

2:00 a.m. Nov. 16, 2023

- Josh Nathan-Kazis

Bristol Myers started at hold with $55 stock price target at Deutsche Bank

10:27 a.m. Nov. 9, 2023

- Tomi Kilgore

FDA Looking Into CAR T Therapies on Cancer Risk

3:00 p.m. Nov. 28, 2023

- The Wall Street Journal Interactive Edition

Corrections & Amplifications

2:35 a.m. Nov. 24, 2023

- The Wall Street Journal Interactive Edition

Stocks Extend Rally, Boosted by AI Optimism

2:33 a.m. Nov. 21, 2023

- The Wall Street Journal Interactive Edition

Bayer Stock Falls On Trial Halt, Roundup Verdict

5:30 p.m. Nov. 21, 2023

- The Wall Street Journal Interactive Edition

Health Care Roundup: Market Talk

6:44 a.m. Oct. 10, 2023

- The Wall Street Journal Interactive Edition

Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion

9:13 a.m. Oct. 9, 2023

- The Wall Street Journal Interactive Edition

The Big Pharma Trade: Ozempic Is In, Covid-19 Is Out

1:32 a.m. Sept. 27, 2023

- The Wall Street Journal Interactive Edition

Uncle Sam Wants You—to Fight High Drug Prices

9:16 a.m. Sept. 25, 2023

- The Wall Street Journal Interactive Edition

This Cancer Therapy is Lifesaving, but There Isn’t Enough of It

1:33 a.m. Sept. 22, 2023

- The Wall Street Journal Interactive Edition

Eliquis for $55 a Month? That Is News to Us

1:33 a.m. Sept. 13, 2023

- The Wall Street Journal Interactive Edition

Big Pharma’s Battle With the Biden Administration Could Have Legs

8:46 a.m. Sept. 13, 2023

- The Wall Street Journal Interactive Edition

Drug Price Controls Mean Slower Cures

3:44 p.m. Aug. 30, 2023

- The Wall Street Journal Interactive Edition

Expensive Drugs Targeted for First U.S. Price Negotiations

2:40 p.m. Oct. 10, 2023

- The Wall Street Journal Interactive Edition

The High Cost of Price Controls on Eliquis and Other Drugs

1:34 a.m. Aug. 30, 2023

- The Wall Street Journal Interactive Edition

Andreessen Co-Leads $200 Million Investment in Biotech Startup Genesis Therapeutics

1:32 a.m. Aug. 22, 2023

- The Wall Street Journal Interactive Edition

Could Scientist Find Drug to Treat His Own Disease?

9:54 a.m. Aug. 14, 2023

- The Wall Street Journal Interactive Edition

U.S. Plan to Negotiate Drug Prices Faces Fresh Industry Fire

1:32 a.m. June 22, 2023

- The Wall Street Journal Interactive Edition

Cancer Doctors Rethink Aggressive Treatments

1:33 a.m. June 6, 2023

- The Wall Street Journal Interactive Edition

Elizabeth Warren and the FTC Are the Least of Amgen’s Problems

1:32 a.m. May 25, 2023

- The Wall Street Journal Interactive Edition

Patients Lose Access to Free Medications as Drugmakers and Insurers Spar

1:33 a.m. May 3, 2023

- The Wall Street Journal Interactive Edition